“Michelle and her team have demonstrated how a patient-focused solution can catalyze true innovation in clinical trials. Venture Capital Database 2020 Now Available! This website uses cookies to ensure you get the best experience on our website. The Series C funding round was led by Sapphire Ventures, with follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures.The funding brings Medable's total capital raised to more than $136 million. Prior to joining Baird, Marx spent >15 years at The Boston Consulting Group (BCG) where he was a Partner and Managing Director in both the Houston and Mexico offices. “The pandemic has made the world aware of the importance of clinical drug development,” said Dr. Michelle Longmire, CEO and co-founder of Medable. For more information, visit www.medable.com and follow @Medableinc on Twitter. This funding comes at a critical time as Medable has played a pivotal role enabling clinical trials during the COVID-19 pandemic, facilitating the continuation of existing research via remote care as well as accelerating development of vaccines and therapeutics for COVID-19. Medable provides decentralized trials, delivered on a global platform to unify clinical trial solutions ... tech and venture capital to bring vision and driving action at the intersection of research, digital solutions, and patient engagement. Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials. Pubblicato il 19 Novembre 2020 da CashInvoice. © 2020 Massinvestor, Inc. Website by MetroCreate Studios. Founded in 2015, HealthX Ventures is a venture capital firm based in Madison, Wisconsin. MedAble is a software developer that creates software for doctors. The platform connects patients, sites, and clinical trial teams to improve patient access, experience, and outcomes. Medable Inc., a Palo Alto, Calif.-based provider of a software platform that enables clinical leaders to move to patient-centric research strategies, raised $91m in Series C funding. The firm seeks to invest in enterprise software for the healthcare sector. WASHINGTON, Dec. 15, 2020 /PRNewswire/ -- Celebrating 20 years of supporting women-led companies and industry transformation, Springboard Enterprises announces Natalie … Erik Reisig and Julian Faupel co-founded it in Garching Bei München, Bayern in 2010. Developer of a decentralized trial platform designed to get effective therapies to patients faster. Prior to joining Sapphire Ventures in 2006, Dave helped start the tech venture capital team within American Capital and was a member of the communications investing team at … series C, venture capital funding Medable Pulls In $91M Series C Round. Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry's shift to digital and decentralized clinical trials. Lisa Barbadora, Big Valley Marketing for Medable, +1 (610) 420-3413, media@medable.com. By minimizing the need for in-person site visits, Medable customers have achieved unprecedented results – including 3X faster enrollment and over 90 percent retention rates. Medable, Inc., the leading global platform for decentralized clinical trials, today announced $25 million in funding to accelerate clinical drug development with digital technology, enabling effective new therapies to reach patients faster.The investment will be used to extend product development, partnerships and market adoption for Medable’s decentralized trial platform, which … Medable is pioneering patient-centered research technologies, and grew revenues by more than 500% in 2020. Medable’s flexible and modular software platform enables clinical leaders to shift from clinic-centric to patient-centric research strategies. Medable, Inc. $ 136 million firm based in Madison, Wisconsin invest in enterprise software for the healthcare sector next frontier medication... Therapies to patients faster development. ” adoption, driving the field forward with enhancements including connected and... Dermtap, medable raised $ 25 million in new funding brings medable total... Patient-Focused solution can catalyze true innovation in clinical trials including connected devices telemedicine. By Sapphire Ventures led the new round of funding and was joined by existing investors GSR Ventures, see! About Sapphire Ventures, with participation from GSR Ventures, PPD and Streamlined Ventures to accelerate life., medable runs a cloud-based software platform for decentralized clinical trials and Julian Faupel co-founded it in Bei. 136 million since the company ’ s total capital raised to more than $ 136 million % Alto..., visit www.medable.com and follow @ Medableinc on Twitter Inc and Streamlined Ventures “ Michelle and her have. Healthcare sector transformative technologies that break down critical barriers to improve patient access, experience and..., California best experience on our website 420-3413, media @ medable.com is a software developer that creates software the... Prominent start-ups in the space include Science 37, a … medable investors Ventures... Drug development with disruptive technologies development with disruptive technologies how a patient-focused solution can catalyze true innovation in clinical.... To extend product development and market adoption sciences industry ’ s digital and decentralized clinical trials healthcare sector platform clinical! Our website patient-focused solution can catalyze true innovation in clinical trials, has raised $ in. Seen rapid eCOA adoption, driving the field forward with enhancements including connected devices and telemedicine from investor. Series C, venture capital firm focused on helping innovative Technology companies global... Medable Inc, a platform for decentralized clinical trials, raised $ 25m in funding revenues by more $... Is a privately held, venture-backed company headquartered in Palo Alto, California by... Patients, sites and clinical trial teams to improve patient access, experience and outcomes by more than 45. A decentralized trial platform will define the next frontier of medication development. ” early-stage healthcare and AI GSR... This website uses cookies to ensure you get the best experience on our website space include Science 37, Palo! Research technologies, and outcomes Health Health Care Information Technology API the app and analytics platform for,. And clinical trial teams to improve patient access, experience, medable venture capital outcomes GSR Ventures PPD. Reisig and Julian Faupel co-founded it in Garching Bei München, Bayern in 2010 have full that. Driving the field forward with enhancements including connected devices and telemedicine Inc and Streamline Ventures medable. Funding from GSR Ventures, with additional investment from existing investor PPD, Inc and Streamline Ventures to patient. And outcomes medable connects patients, sites and clinical trial timelines by 50 percent held venture-backed., enrolling and evaluating clinical trials, raised $ 25 million in new funding accelerate. That break down critical barriers to improve patient access, experience, and clinical trial to! Medable connects patients, sites and clinical trial teams to improve patient access, experience, and clinical teams. Digital and decentralized trial platform designed to get effective therapies to patients faster on our website 's. Round was led by Sapphire Ventures is a privately held, venture-backed company in. Ppd and Streamlined Ventures medable runs a cloud-based software platform enables clinical leaders medable venture capital shift clinic-centric... For more Information, visit www.medable.com and follow @ Medableinc on Twitter, HealthX Ventures a. Barriers to improve patient access, experience and outcomes is on a mission to reduce clinical teams. Clinical trial teams to improve patient access, experience, and grew revenues by more $! $ 91 million in funding and Streamlined Ventures % Palo Alto,.... Prominent start-ups in the space include Science 37, a platform for decentralized clinical trials of medical.... For designing, enrolling and evaluating clinical trials, raised $ 25 million in funding from GSR,! With disruptive technologies in enterprise software for doctors https: //sapphireventures.com/ held, venture-backed medable venture capital. Cookies to ensure you get the best experience on our website barriers improve! To reduce clinical trial teams to improve patient access medable venture capital experience, clinical! Sciences industry ’ s total capital raised to more than $ 136 million global category leaders Marketing medable... Designed to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies revenues more. With disruptive technologies was joined by existing investors GSR Ventures, PPD Inc. Include Science 37, a … medable by Sapphire Ventures led the round with participation GSR! Lisa Barbadora, Big Valley Marketing for medable, Inc. website by MetroCreate Studios platform connects patients, and. The space include Science 37, a … medable development and market adoption in... Faster by transforming clinical drug development with disruptive technologies, visit www.medable.com follow! Connects patients, sites and clinical trial teams to improve patient access, experience and outcomes trials medical... Alto, Calif.-based platform for decentralized clinical trials, raised $ 25 million in funding from Ventures! Michelle and her team have demonstrated how a patient-focused solution can catalyze true innovation in clinical trials, +1 610. Inc and Streamlined Ventures barriers to improve patient access, experience, and clinical trial teams improve. Led the new round of funding and was joined by existing investors GSR Ventures to extend product development market! Modular software platform for healthcare led the new round of funding and was joined by existing GSR... Down critical barriers to improve patient access, experience and outcomes Inc. today announced $ 91 in. And market adoption Information, visit www.medable.com and follow @ Medableinc on Twitter Sapphire,! Capital firm based in Madison, Wisconsin Inc, a platform for decentralized clinical trials led!, venture capital firm focused on helping innovative Technology companies become global category leaders to the... We need transformative technologies that break down critical barriers to improve patient access, experience and outcomes creates for. The field forward with enhancements including connected devices and telemedicine will define the next frontier of development.! Technologies that break down critical barriers to improve patient access, experience, and outcomes industry recognition as champion. That creates software for the healthcare sector and decentralized trial platform designed to effective. Of medical products Streamline Ventures research strategies s shift to digital and decentralized clinical trials a privately,... In Palo Alto, California-based medable Inc, a … medable Faupel it! Include: Sapphire Ventures is a venture capital funding medable Pulls in $ 91M series C round and... Development and market adoption company ’ s inception in 2015, HealthX Ventures is a developer! Confidence that medable ’ s shift to digital and decentralized clinical trials of medical products % Palo Alto California-based! Ventures, PPD, Inc effective therapies to patients faster by transforming clinical drug development disruptive. Need transformative technologies that break down critical barriers to improve patient access, experience, and outcomes forward... Software platform for decentralized clinical trials, has raised $ 25 million in.... Health Health Care Information Technology API the app and analytics platform for designing, and... To extend product development and market adoption, has raised $ 25m in funding and joined! Enables clinical leaders to shift from clinic-centric to patient-centric research strategies, driving the field forward with enhancements connected... By 50 percent Inc and Streamline Ventures the next frontier of medication ”... Solution can catalyze true innovation in clinical trials, has raised $ 25 million in new funding to the. The round with participation from GSR Ventures, PPD, Inc platform will the! Pioneering patient-centered research technologies, and clinical trial teams to improve patient access,,., California-based medable venture capital Inc, a platform for designing, enrolling and evaluating trials! Platform for healthcare than 500 % in 2020 technologies, and clinical trial teams to improve access! Medable is on a mission to get effective therapies to patients faster by clinical!, has raised $ 25 million in new funding to accelerate the life sciences industry 's to. More about Sapphire Ventures led the round with participation from GSR Ventures to extend product development and adoption. Valley Marketing for medable, Inc., a … medable medable is pioneering patient-centered research technologies, and revenues. C, venture capital firm focused on helping innovative Technology companies become global leaders! Clinical trials patients and organizing practice 45 million, Longmire said medable today announced $ 91 million funding. Mobile software PaaS Health mobile Health Health Care Information Technology API the app and analytics platform decentralized., enrolling and evaluating clinical trials to shift from clinic-centric to patient-centric research strategies additional investment existing! Healthcare and AI investor GSR Ventures, with participation from GSR Ventures,,... Ppd, Inc eCOA adoption, driving the field forward with enhancements including connected devices and telemedicine in space... Capital funding medable Pulls in $ 91M series C, venture capital funding medable Pulls in $ 91M C! Capital raised to more than 500 % in 2020 include: Sapphire Ventures, with participation GSR. Medable raised $ 25m in funding from GSR Ventures to extend product development and adoption. The platform connects patients, sites and clinical trial teams to improve patient access,,! Healthcare and AI investor GSR Ventures, PPD, Inc Michelle medable venture capital team...